|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
about 14 years ago
Emerging Pharma Leaders 2012about 14 years ago
Who Will Pay for New Drugs?about 14 years ago
Less, But Betterabout 14 years ago
John Lechleiter on PhRMA and Innovationabout 14 years ago
Today's Mission Critical: Making Sense of Spending on Clinical Trialsabout 14 years ago
The Learning Curveabout 14 years ago
Marketing: Why the Conversation Has Changed — ForeverAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Value Imperative to Operating Reality: Rethinking Trust in Pharma
2
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
3
FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma
4
The Road Ahead: Advice for Pharma's Next Board Meeting
5